WIN 55212-2 mesylate
Modify Date: 2024-01-01 22:17:21
WIN 55212-2 mesylate structure
|
Common Name | WIN 55212-2 mesylate | ||
|---|---|---|---|---|
| CAS Number | 131543-23-2 | Molecular Weight | 522.613 | |
| Density | N/A | Boiling Point | 627.7ºC at 760 mmHg | |
| Molecular Formula | C28H30N2O6S | Melting Point | N/A | |
| MSDS | USA | Flash Point | 333.4ºC | |
Use of WIN 55212-2 mesylateWIN 55,212-2 Mesylate is a potent aminoalkylindole cannabinoid (CB) receptor agonist with Kis of 62.3 and 3.3 nM for human recombinant CB1 and CB2 receptors, respectively. |
| Name | (+)-Win 55212-2 mesylate |
|---|---|
| Synonym | More Synonyms |
| Description | WIN 55,212-2 Mesylate is a potent aminoalkylindole cannabinoid (CB) receptor agonist with Kis of 62.3 and 3.3 nM for human recombinant CB1 and CB2 receptors, respectively. |
|---|---|
| Related Catalog | |
| Target |
Ki: 62.3 nM (human recombinant CB1), 3.3 nM (human recombinant CB2) |
| In Vitro | WIN 55,212-2 is more potent in CHO-CB2 cells than in CHO-CB1 cells by a factor of 6O. WIN 55,212-2 has no effect on arachidonic acid release in CHO-CB2 or control CHO cells. WIN 55,212-2 fails to stimulate any increase in intracellular Ca2+ up to 10 μM[1]. In primary cultures of rat cerebral cortex neurons, WIN 55,212-2 (0.01--100 nM) increases extracellular glutamate levels, displaying a bell-shaped concentration-response curve. The facilitatory effect of WIN 55,212-2 (1 nM) is fully counteracted by SR141716A (10 nM), by the replacement of the normal Krebs Ringer-bicarbonate buffer with a low Ca2+ medium (0.2 mM) and by the IP(3) receptor antagonist xestospongin C (1 μM)[2]. WIN 55,212-2 evokes CGRP release from TG neurons in vitro (EC50=26 μM) in a concentration- and calcium-dependent manner. WIN 55,212-2-2 neither inhibits capsaicin-evokes CGRP release nor does it inhibit forskolin-, isoproteranol- or prostaglandin E2-stimulated cAMP accumulation. WIN 55,212-2 significantly inhibits (EC50=1.7 μM) 50 mm K+-evoked CGRP release by approximately 70%. WIN 55,212-2 inhibition of 50 mm K+-evoked CGRP release is not reversed by antagonists of cannabinoid type 1 (CB1) receptor, but is mimicks in magnitude and potency (EC50=2.7 μM) by its cannabinoid-inactive enantiomer WIN 55,212-2-3[3]. |
| In Vivo | In the prefrontal cortex WIN 55,212-2 (0.1 and 1 mg/kg i.p.) increases dialysate glutamate levels from of the awake rat, while the lower (0.01 mg/kg) and the higher (2 mg/kg) doses are ineffective. Furthermore, the WIN 55,212-2 (0.1 mg/kg)- induced increase of dialysate glutamate levels is counteracted by pretreatment with the selective CB(1) receptor antagonist SR141716A (0.1 mg/kg, i.p.) and by the local perfusion with a low-calcium Ringer solution (Ca2+ 0.2 mM)[2]. WIN 55,212-2 (0.5, 1, 3, 5, 10 and 15 mg/kg, i.p.) does not alter the seizure threshold at low doses, while higher doses of the drug significantly increases the threshold in a dose-dependent manner. The anticonvulsant effect of WIN 55,212-2, which is observed with doses as high as 5 mg/kg, can be observed with doses as low as 0.5 mg/kg in groups pre-treated with 20 mg/kg of pioglitazone[4]. |
| Animal Admin | In experiment 1, different doses of WIN 55,212-2 (0.5, 1, 3, 5, 10 and 15 mg/kg) are injected 60 min prior to the determination of clonic seizure threshold induced by intravenous administration of PTZ solution. Control animals receive the same volume of the vehicle (1% aqueous solution of DMSO). The doses and time point are chosen on the basis of pilot studies. In experiment 2, in order to confirm the anticonvulsant effects of pioglitazone, different doses (10, 20, 40 and 80 mg/kg) are administered 4 h prior to PTZ in distinct groups of mice. The corresponding control groupreceive the appropriate vehicle (CMC 1%) at the same time point. In experiment 3, The additive anti epileptic effects of WIN 55,212-2 and pioglitazone are examined; mice receive acute administration of pioglitazone (10 or 20 mg/kg) 3 h before WIN 55,212-2 (0.5 or 1 mg/kg) and 4 h before PTZ. |
| References |
| Boiling Point | 627.7ºC at 760 mmHg |
|---|---|
| Molecular Formula | C28H30N2O6S |
| Molecular Weight | 522.613 |
| Flash Point | 333.4ºC |
| Exact Mass | 522.182434 |
| PSA | 106.45000 |
| LogP | 5.12230 |
| Vapour Pressure | 1.14E-15mmHg at 25°C |
| Storage condition | Store at +4°C |
| Water Solubility | 0.1 M HCl: 0.25 mg/mL |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Nat. Chem. Biol. 3(5) , 268-273, (2007) The identification of self-renewing and multipotent neural stem cells (NSCs) in the mammalian brain holds promise for the treatment of neurological diseases and has yielded new insight into brain canc... |
|
|
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Nat. Chem. Biol. 5 , 765-71, (2009) Studies of gene function and molecular mechanisms in Plasmodium falciparum are hampered by difficulties in characterizing and measuring phenotypic differences between individual parasites. We screened... |
|
|
Activation of the endocannabinoid system by organophosphorus nerve agents.
Nat. Chem. Biol. 4 , 373-8, (2008) Delta(9)-tetrahydrocannabinol (THC), the psychoactive ingredient of marijuana, has useful medicinal properties but also undesirable side effects. The brain receptor for THC, CB(1), is also activated b... |
| (R)-(+)-WIN 55,212-2 mesylate salt |
| Methanone, [(3R)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)-1,4-oxazino[2,3,4-hi]indol-6-yl]-1-naphthalenyl-, methanesulfonate (1:1) |
| WIN 55,212-2 (Mesylate) |
| (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone mesylate |
| WIN 55,212-2 |
| WIN55212-2 mesylate |
| (R)-(5-Methyl-3-(morpholinomethyl)-2,3-dihydro-[1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1-yl)methanone methanesulfonate |
| Lopac-W-102 |
| WIN 55,212-2 mesylate |
| WIN 55212-2 mesylate |
| [(3R)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenyl-methanone, monomethanesulfonate |
| [(3R)-5-Methyl-3-(4-morpholinylmethyl)-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl](1-naphthyl)methanone methanesulfonate (1:1) |
| (R)-(+)-[2,3-Dihydro-5-methyl-3[(4-morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate salt |
| ( R)-(+)-WIN 55,212-2 mesylate |
| (R)-(5-Methyl-3-(morpholinomethyl)-2,3-dihydro-[1,4]oxazino-[2,3,4-hi]indol-6-yl)(naphthalen-1-yl)methanone methanesulfonate |
| [(3R)-5-Methyl-3-(morpholin-4-ylmethyl)-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl](1-naphthyl)methanone methanesulfonate (1:1) |
| MFCD00153882 |
| R-(+)-WIN 55,212-2 mesylate salt |
| WIN-55212-2 mesylate |
- Shanghai Jizhi Biochemical Technology Co., Ltd
- China
- Product Name: WIN 55212-2 mesylate
- Price: ￥4988.0/25mg ￥10188.0/100mg
- Purity: 98.0%
- Stocking Period: Inquiry
- Contact: Liu jia
- DC Chemicals Limited
- China
- Product Name: WIN-55212-2 mesylate
- Price: $350.0/100mg $700.0/250mg $1350.0/1g
- Purity: 98.0%
- Stocking Period: 3 Day
- Contact: Tony Cao
Get all suppliers and price by the below link:
WIN 55212-2 mesylate suppliers
Price: $69/10mM*1mLinDMSO
Reference only. check more WIN 55212-2 mesylate price